Works matching IS 19466234 AND DT 2023 AND VI 15 AND IP 679
Results: 6
Multiplex epigenome editing of MECP2 to rescue Rett syndrome neurons.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 679, p. 1, doi. 10.1126/scitranslmed.add4666
- By:
- Publication type:
- Article
Allergy: Mechanistic insights into new methods of prevention and therapy.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 679, p. 1, doi. 10.1126/scitranslmed.add2563
- By:
- Publication type:
- Article
S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 679, p. 1, doi. 10.1126/scitranslmed.abq4064
- By:
- Publication type:
- Article
CD200<sup>+</sup> cytotoxic T lymphocytes in the tumor microenvironment are crucial for efficacious anti–PD-1/PD-L1 therapy.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 679, p. 1, doi. 10.1126/scitranslmed.abn5029
- By:
- Publication type:
- Article
Targeting de novo lipid synthesis induces lipotoxicity and impairs DNA damage repair in glioblastoma mouse models.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 679, p. 1, doi. 10.1126/scitranslmed.abq6288
- By:
- Publication type:
- Article
The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's disease.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 679, p. 1, doi. 10.1126/scitranslmed.abp9352
- By:
- Publication type:
- Article